The US Securities and Exchange Commission (SEC) has put the debut of over 20 prediction-market ETFs on hold. This pause follows the SEC's request for additional information from ETF issuers regarding the structure of these funds. The delay highlights regulatory scrutiny on new financial products that involve prediction markets, which could impact their launch timeline. Investors should watch for further updates as issuers respond to the SEC's inquiries.
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...
Corbin Advisors' Q2 2026 survey shows industrial investor sentiment at its highest in five years, with 84% of participants bullish or neutral-to-bullish due to strong order momentum and demand from data centers and AI sectors. Expectations for Q2 rev...
IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million, with an additional earnout of up to €50 million based on performance. This acquisition will expand IPG's Advanced Solutions portfolio in medical lasers, particularl...
Constellation Software Inc. announced it will hold a conference call and live webcast on August 12, 2026, at 8:00 a.m. ET to discuss its second quarter results. The company will release its quarterly earnings after the Toronto Stock Exchange closes o...
XRP is trading in a tight range around $1.10, showing little price movement despite signals of large whale accumulation and increased derivatives activity. Regulatory developments in the US, including a congressional hearing on XRP's classification, ...
